Care Access Las Vegas

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Crohn's disease2 trials
• Ulcerative colitis1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Active, not recruiting3 trials

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Eli Lilly and Company1 trial

Running trials

• Active, not recruiting

  A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT05242484· Phase 2· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT05242471· Phase 2· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

  NCT04232553· Phase 3· Eli Lilly and Company· Source